Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

207 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Recruiting

A Study of BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

NCT06891833

Conditions
HER2-positive Breast Cancer
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View all 30 locations
View Trial Details
Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

NCT07102381

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Oncology Institute Long Beach, California, United States
  • Cancer & Blood Research Center Los Alamitos, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
View all 35 locations
View Trial Details
Recruiting

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

NCT07459673

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +6 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

ATEMPT 2.0: Adjuvant T-DM1 vs TH

NCT04893109

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Smilow Cancer Hospital Care center at Derby Derby, Connecticut, United States
  • Smilow Cancer Hospital Care center at Fairfield Fairfield, Connecticut, United States
  • Smilow Cancer Hospital Care center at Glastonbury Glastonbury, Connecticut, United States
View all 53 locations
View Trial Details

Related conditions